The global digital therapeutics market encompasses technology-based interventions treating medical conditions. Utilizing digital platforms, these solutions deliver evidence-based therapeutic interventions, leveraging software to engage patients and modify behavior. Digital therapeutics encompass a broad spectrum, including mobile apps, wearable devices, and online platforms, targeting conditions such as diabetes, mental health disorders, and respiratory diseases. With ongoing developments in telemedicine and healthcare technology, the global digital therapeutics market continues to evolve, addressing diverse healthcare challenges.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-digital-therapeutics-market
Data Bridge Market Research analyses that the Global Digital Therapeutics Market which was USD 4,300.00 million in 2022, is expected to reach USD 20,421.08 million by 2030, and is expected to undergo a CAGR of 21.5% during the forecast period 2023-2030. Remote patient monitoring, facilitated by digital therapeutics, enables healthcare providers to track and manage patients' health conditions beyond traditional settings. This growing adoption enhances real-time monitoring, promotes proactive intervention, and contributes to improved patient outcomes by providing continuous, remote healthcare support.
Key Findings of the Study
Telehealth expansion is expected to drive the market's growth rate
The widespread adoption of telehealth services and the ongoing digitalization of healthcare systems contribute to the seamless integration and acceptance of digital therapeutics into routine medical practices. Telehealth expansion facilitates the delivery of remote healthcare services, making it easier for patients to access digital therapeutics, fostering a more patient-centric approach to healthcare delivery, and enhancing the overall efficiency and effectiveness of medical interventions.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Software and Devices), Sales Channel (B2C and B2B), Application (Preventive Applications and Treatment/Care-related Applications)
|
|
Countries Covered
|
U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E., Kuwait, Israel, Egypt, and Rest of Middle East and Africa
|
|
Market Players Covered
|
Omada Health, Inc. (U.S.), ResMed (U.S.), Pear Therapeutics, Inc. (U.S.), Solera Network (U.S.), Akili Interactive Labs, Inc. (U.S.), Better Therapeutics, LLC (U.S.), Biofourmis (U.S.), Click Therapeutics, Inc. (U.S.), Naturalcycles Nordic AB (Sweden), NuvoAir AB (Sweden), Welldoc’s Bluestar (U.S.), Happify, Inc. (U.S.), Limbix Health, Inc. (U.S.), Voluntis (U.S.), Xealth (U.S.)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The global digital therapeutics market is segmented on the basis of product type, sales channel, and application.
- On the basis of product type, the global digital therapeutics market is segmented into software and devices
- On the basis of sales channel, the global digital therapeutics market is segmented into B2C and B2B
- On the basis of application, the global digital therapeutics market is segmented into preventive applications and treatment/care-related applications
Major Players
Data Bridge Market Research recognizes the following companies as the major global digital therapeutics market players in global digital therapeutics market are Biofourmis (U.S.), Click Therapeutics, Inc. (U.S.), Naturalcycles Nordic AB (Sweden), NuvoAir AB (Sweden), Welldoc’s Bluestar (U.S.), Happify, Inc. (U.S.), Limbix Health, Inc. (U.S.), Voluntis (U.S.), Xealth (U.S.)
Market Developments
- In February 2022, Biofourmis unveiled Biofourmis Care, a tech-driven care management service for chronic condition patients. Integrating automated medication management, empowers care teams to remotely fine-tune medications for personalized therapy. This strategic initiative has enhanced health outcomes and curtailed overall patient care costs. Biofourmis' innovative approach positions it as a key player, contributing significantly to industry revenue while advancing the trajectory of remote care in the healthcare market
- In December 2021, Teladoc extended its partnership with the National Labour Alliance, broadening its virtual care offerings. The expanded agreement encompassed a comprehensive range of services, including specialty care, general medical consultations, expert medical services, mental health support, virtual primary care programs, and chronic disease management. This collaboration aimed to provide a diverse and extensive suite of virtual healthcare solutions to cater to a wide spectrum of healthcare needs for the National Labour Alliance and its members
- In March 2021, Pear Therapeutics Inc. partnered with Spectrum Health Systems, a leading addiction treatment provider under Tufts Health Plan. This partnership aims to advance treatment access and care innovation for substance use disorders. By combining Pear Therapeutics' digital therapeutics, Spectrum Health Systems' addiction treatment expertise, and Tufts Health Plan's extensive reach and resources, this alliance holds promise in significantly impacting the lives of individuals grappling with addiction, marking a crucial step in addressing the challenges posed by substance use disorders
- In October 2020, Livongo forged a strategic partnership with Guidewell Mutual Holding Corporation, granting Livongo access to Guidewell's select members. This partnership enables Livongo to extend its comprehensive virtual care experience to Guidewell consumers with diabetes. Leveraging connected devices, advanced data science, and telehealth, Livongo aims to enhance the healthcare journey for these members, fostering an end-to-end solution. This strategic move is poised to expand Livongo's customer base and solidify its position in the healthcare technology market
Regional Analysis
Geographically, the countries covered in the global digital therapeutics market report are U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E., Kuwait, Israel, Egypt, and Rest of Middle East and Africa
As per Data Bridge Market Research analysis:
North America is the dominant region in the global digital therapeutics market during the forecast period 2023-2030
North America dominates the global digital therapeutics market with a robust healthcare infrastructure, a concentration of major industry players, and extensive healthcare facilities. The region's advanced healthcare system, coupled with a substantial population afflicted by chronic diseases, positions it as a key hub for digital therapeutic solutions. The strong foundation of healthcare resources and technological advancements further solidify North America's leadership in driving growth and innovation within the digital therapeutics market.
Asia-Pacific is estimated to be the fastest-growing region in the global digital therapeutics market during the forecast period 2023-2030
Asia-Pacific is expected to dominate the global digital therapeutics market from 2023 to 2030. This growth is attributed to increased government initiatives promoting healthcare, rising health awareness, and a growing demand for advanced medical technology to manage chronic diseases. The region's large population pool and escalating demand for quality healthcare further contribute to the significant expansion of the digital therapeutics market in the Asia-Pacific region during the forecast period.
For more detailed information about the global digital therapeutics market report, click here – https://www.databridgemarketresearch.com/reports/global-digital-therapeutics-market
